Home Overview Press Room Blog Publications For Students about us

Personal genomics : Displaying 225-244 of 532

Direct-to-Consumer Genomics Reinvents Itselfby Malorye AllisonNatureNovember 8th, 2012Consumer demand is not as high as direct-to-consumer gene testing companies had hoped.
Personalised Medicine: A Reality Checkby Donna DickensonBioNewsNovember 5th, 2012A look at the economic and political realities that lurk behind the lofty promises made by the advocates of personalised medicine.
Why I Don’t Want to Know My Genome Sequenceby Ricki LewisPLOS BlogsNovember 1st, 2012The author of ten editions of a human genetics textbook is choosing not to have her genome sequenced because she believes the tests provide both too much and too little information.
Genetic Profiteering: Scandal of Firm 'Hiding Vital Breast Cancer Data' by Steve ConnorThe IndependentNovember 1st, 2012Myriad Genetics is accused of deliberately withholding data that could help other scientists to understand cancer genetics, on the grounds that the information is commercially sensitive.
Medical Students’ DNA – and Psychology – on Display in Classroomby Jessica CussinsBiopolitical TimesOctober 31st, 2012A class at Mount Sinai Medical School is the first to allow students to sequence and analyze entire genomes. The class is also an experiment: Researchers will be analyzing students’ responses to determine the psychological consequences of such sensitive information.
Genetic Breakthrough at OHSU[With CGS's Marcy Darnovsky]by Allison FrostOregon Public RadioOctober 29th, 2012Researchers in Oregon have created a viable human embryo by combining genetic material from two women's eggs, raising safety and ethical questions.
Why Cheaper Genetic Testing Could Cost Us a Fortuneby Bonnie RochmanTimeOctober 26th, 2012Experts are concerned that new genetic tests will increase overall health care spending and that test results will make it harder for people to get insurance.
Test Your DNA for Diseases — No Doctor Requiredby Bonnie RochmanTimeOctober 23rd, 2012Even as physicians and bioethicists wrestle with the implications of whole-genome sequencing, companies like 23andMe are planning to make it available directly to the public.
Will My Son Develop Cancer? The Promise (and Pitfalls) of Sequencing Children’s Genomes by Bonnie RochmanTimeOctober 22nd, 2012Can you imagine wanting to know whether your newborn baby will fall victim to Alzheimer’s disease decades down the road? What about cancer or diabetes?
Personal Genomics in the Classroom: Students Sequence Themselvesby Monya BakerNature News BlogOctober 11th, 2012Medical and graduate students will get the chance to sequence and interpret their own genomes in what is being billed as the first-ever course to offer whole-genome sequencing.
Citing Privacy Concerns, U.S. Panel Urges End to Secret DNA Testingby Sharon BegleyReutersOctober 11th, 2012In response to companies that offer genome sequencing from such discarded items as cigarette butts, the President's bioethics commission stresses privacy concerns and suggests a ban on "surreptitious commercial testing."
Prenatal Test Presents Dilemmas to Expectant Mothersby Maureen SalamonUS NewsSeptember 28th, 2012Some women label information about fetal chromosomal abnormalities "toxic knowledge" they wish they hadn't received, a small new study shows.
Anatomy of a Webpage: Marketing Fetal Gene Tests and Sequenom’s MaterniT21by George EstreichBiopolitical Times guest contributorSeptember 24th, 2012In the age of genomics, whole-chromosome conditions are only the beginning. Our ability to sample fetal DNA from maternal blood means that not only Down syndrome, but before long any condition with a genetic component, any “risk,” can be forecast.
An API for Genome AppsThe Daily ScanSeptember 20th, 2012Direct-to-consumer gene test company 23andMe will allow third-party developers to create applications that piggyback on customers' personal genome data.
Potential Perils of DIY Genetic Testingby Anna SallehABC NewsSeptember 11th, 2012A new study adds to growing concern about the potential perils of direct-to-consumer genetic tests.
Yet Another Study Claims to Find Politics in Our Genes by Jessica CussinsBiopolitical TimesSeptember 6th, 2012A study on genes and political identity comes out just in time for the presidential election, but says little that’s new.
Bits of Mystery DNA, Far From ‘Junk,’ Play Crucial Roleby Gina KolataThe New York TimesSeptember 5th, 2012At least four million gene switches that reside in sections of the human genome once thought to be inactive turn out to have critical functions in the body, researchers reported.
Genes Now Tell Doctors Secrets They Can’t Utterby Gina KolataNew York TimesAugust 25th, 2012In laboratories around the world, genetic researchers using tools that are ever more sophisticated to peer into the DNA of cells are increasingly finding things they were not looking for.
Human Genes - Sold to the Highest Bidder?Federal Appeals Court Ruled that Myriad Can in Fact Patent Isolated Human Genes by Jessica CussinsBiopolitical TimesAugust 23rd, 2012A U.S. federal appeals court has reaffirmed that gene patents are legal in its ruling last week that Myriad Genetics can keep its patent on the BRCA1 and BRCA2 genes.
Who's Your Daddy? DNA Clinic Gives Answers, Sparks Concernsby Lily KuoReutersAugust 22nd, 2012A mobile DNA testing facility is raising questions about the ramifications of quick and easy tests to determine paternity and other biological connections.
Displaying 225-244 of 532  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760